412 related articles for article (PubMed ID: 22749192)
41. Optimization of gefitinib analogues with potent anticancer activity.
Yin KH; Hsieh YH; Sulake RS; Wang SP; Chao JI; Chen C
Bioorg Med Chem Lett; 2014 Nov; 24(22):5247-50. PubMed ID: 25305687
[TBL] [Abstract][Full Text] [Related]
42. Synthesis of aminoquinazoline derivatives and their antiproliferative activities against melanoma cell line.
Lee J; Nam BS; Kim H; Oh CH; Lee SH; Cho SJ; Sim TB; Hah JM; Kim DJ; Tae J; Yoo KH
Bioorg Med Chem Lett; 2010 Oct; 20(19):5722-5. PubMed ID: 20797858
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and antitumor activity of formononetin nitrogen mustard derivatives.
Ren J; Xu HJ; Cheng H; Xin WQ; Chen X; Hu K
Eur J Med Chem; 2012 Aug; 54():175-87. PubMed ID: 22633834
[TBL] [Abstract][Full Text] [Related]
44. Design and Synthesis of 4-substituted Quinazolines as Potent EGFR Inhibitors with Anti-breast Cancer Activity.
Ahmed MF; Magdy N
Anticancer Agents Med Chem; 2017; 17(6):832-838. PubMed ID: 27671305
[TBL] [Abstract][Full Text] [Related]
45. Design and synthesis of 4-amino-2-phenylquinazolines as novel topoisomerase I inhibitors with molecular modeling.
Le TN; Yang SH; Khadka DB; Van HT; Cho SH; Kwon Y; Lee ES; Lee KT; Cho WJ
Bioorg Med Chem; 2011 Jul; 19(14):4399-404. PubMed ID: 21684168
[TBL] [Abstract][Full Text] [Related]
46. Synthesis and antitumor activity of β-carboline 3-(substituted-carbohydrazide) derivatives.
Barbosa VA; Formagio AS; Savariz FC; Foglio MA; Spindola HM; de Carvalho JE; Meyer E; Sarragiotto MH
Bioorg Med Chem; 2011 Nov; 19(21):6400-8. PubMed ID: 21944971
[TBL] [Abstract][Full Text] [Related]
47. Design and synthesis of 4,6-substituted-(diaphenylamino)quinazolines as potent EGFR inhibitors with antitumor activity.
Li HQ; Li DD; Lu X; Xu YY; Zhu HL
Bioorg Med Chem; 2012 Jan; 20(1):317-23. PubMed ID: 22112541
[TBL] [Abstract][Full Text] [Related]
48. Design and synthesis of a quinazolinone natural product-templated library with cytotoxic activity.
Liu JF; Kaselj M; Isome Y; Ye P; Sargent K; Sprague K; Cherrak D; Wilson CJ; Si Y; Yohannes D; Ng SC
J Comb Chem; 2006; 8(1):7-10. PubMed ID: 16398546
[No Abstract] [Full Text] [Related]
49. Synthesis and anticancer activities of 4-(4-substituted piperazin)-5,6,7-trialkoxy quinazoline derivatives.
Zhang Y; Huang YJ; Xiang HM; Wang PY; Hu DY; Xue W; Song BA; Yang S
Eur J Med Chem; 2014 May; 78():23-34. PubMed ID: 24675177
[TBL] [Abstract][Full Text] [Related]
50. Utility of methyl 2-isothiocyanatobenzoate in the synthesis of some new quinazoline derivatives as potential anticancer and radiosensitizing agents.
Ghorab MM; Ragab FA; Heiba HI; Bayomi AA
Arzneimittelforschung; 2011; 61(12):719-26. PubMed ID: 22282960
[TBL] [Abstract][Full Text] [Related]
51. Disubstituted 4(3H) quinazolones: a novel class of antitumor agents.
Srivastava V; Srivastava AM; Tiwari AK; Srivastava R; Sharma R; Sharma H; Singh VK
Chem Biol Drug Des; 2009 Sep; 74(3):297-301. PubMed ID: 19703032
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and antitumor activity of ring A modified glycyrrhetinic acid derivatives.
Csuk R; Schwarz S; Siewert B; Kluge R; Ströhl D
Eur J Med Chem; 2011 Nov; 46(11):5356-69. PubMed ID: 21959232
[TBL] [Abstract][Full Text] [Related]
53. Design, synthesis and in vitro biological evaluation of novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives containing a thiosemicarbazide moiety.
Geng PF; Liu XQ; Zhao TQ; Wang CC; Li ZH; Zhang J; Wei HM; Hu B; Ma LY; Liu HM
Eur J Med Chem; 2018 Feb; 146():147-156. PubMed ID: 29407946
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and antiproliferative evaluation of 13-aryl-13H-benzo[g]benzothiazolo [2,3-b]quinazoline-5,14-diones.
Wu L; Zhang C; Li W
Bioorg Med Chem Lett; 2014 Mar; 24(6):1462-5. PubMed ID: 24582982
[TBL] [Abstract][Full Text] [Related]
55. Design, synthesis and in vitro antitumor activity of 4-aminoquinoline and 4-aminoquinazoline derivatives targeting EGFR tyrosine kinase.
Abouzid K; Shouman S
Bioorg Med Chem; 2008 Aug; 16(16):7543-51. PubMed ID: 18678492
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and cytotoxicity testing of novel 2-(3-substituted-6-chloro-1,1-dioxo-1,4,2-benzodithiazin-7-yl)-3-phenyl-4(3H)-quinazolinones.
Pomarnacka E; Maruszak M; Langowska K; Reszka P; Bednarski PJ
Arch Pharm (Weinheim); 2008 Aug; 341(8):485-90. PubMed ID: 18618486
[TBL] [Abstract][Full Text] [Related]
57. Design, synthesis and structure-activity relationships of novel 4-phenoxyquinoline derivatives containing pyridazinone moiety as potential antitumor agents.
Zhou S; Liao H; He C; Dou Y; Jiang M; Ren L; Zhao Y; Gong P
Eur J Med Chem; 2014 Aug; 83():581-93. PubMed ID: 24996144
[TBL] [Abstract][Full Text] [Related]
58. Identification of potent pyrazolo[4,3-h]quinazoline-3-carboxamides as multi-cyclin-dependent kinase inhibitors.
Traquandi G; Ciomei M; Ballinari D; Casale E; Colombo N; Croci V; Fiorentini F; Isacchi A; Longo A; Mercurio C; Panzeri A; Pastori W; Pevarello P; Volpi D; Roussel P; Vulpetti A; Brasca MG
J Med Chem; 2010 Mar; 53(5):2171-87. PubMed ID: 20141146
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and biological evaluation of novel tricyclic oxazine and oxazepine fused quinazolines. Part 1: erlotinib analogs.
Chen X; Du Y; Sun H; Wang F; Kong L; Sun M
Bioorg Med Chem Lett; 2014 Feb; 24(3):884-7. PubMed ID: 24411123
[TBL] [Abstract][Full Text] [Related]
60. Solvent-free synthesis and anticancer activity evaluation of benzimidazole and perimidine derivatives.
Kumar A; Banerjee S; Roy P; Sondhi SM; Sharma A
Mol Divers; 2018 Feb; 22(1):113-127. PubMed ID: 29143160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
